Dilution is often the primary solution for all OTC stocks... How they approach mitigating is key to defining what potential exists and more importantly likely how quickly a potential solution can reach patients in need.
I take it as a good sign that they appear to recognize the importance and recently got institutional investor to absorb a chunk of debt on company friendly terms and fixed price conversion.
News 
Market Data 
Discover 
